Published in BMC Infect Dis on January 16, 2015
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med (1965) 10.85
Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90
Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med (2000) 6.43
A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc (2007) 5.13
What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis (2004) 4.87
The incidence of herpes zoster. Arch Intern Med (1995) 3.87
Varicella-zoster virus. Clin Microbiol Rev (1996) 3.03
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect (2001) 2.98
Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis (2009) 2.74
Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology (2010) 2.45
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16
Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis (2003) 2.02
Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin (2008) 1.99
Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection (2008) 1.92
Herpes zoster. BMJ (2007) 1.91
Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke (2009) 1.88
Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch Intern Med (2009) 1.71
Clinical and molecular pathogenesis of varicella virus infection. Viral Immunol (2003) 1.67
Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology (Oxford) (2006) 1.61
Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection (2011) 1.52
Association of treatment with losartan vs candesartan and mortality among patients with heart failure. JAMA (2012) 1.52
The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: A retrospective survey in an elderly population. Eur J Pain (1999) 1.46
Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc (2009) 1.42
Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol (2009) 1.38
Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis (1998) 1.27
Herpes zoster virus infection. Curr Opin Ophthalmol (2004) 1.23
Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis (1998) 1.16
Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. Am J Med (2005) 1.16
Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study. CMAJ (2011) 1.15
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine (2009) 1.12
Psychoneuroimmunology and health consequences: data and shared mechanisms. Psychosom Med (1995) 1.12
Is herpes zoster a marker for occult or subsequent malignancy? Br J Gen Pract (2005) 1.04
The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study. Br J Cancer (2013) 1.02
Increased risk of a cancer diagnosis after herpes zoster ophthalmicus: a nationwide population-based study. Ophthalmology (2011) 1.00
Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Clinics (Sao Paulo) (2011) 1.00
Effect of psychosocial factors on physiologic outcomes in patients with heart failure. J Cardiovasc Nurs (2000) 0.96
Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure. Am J Cardiol (2004) 0.87
Herpes zoster and subsequent risk of cancer: a population-based study. J Epidemiol (2013) 0.86
Disseminated zoster in an elderly patient. Infection (2009) 0.84
Herpes zoster as a marker of underlying malignancy. Open Med (2013) 0.82
Human herpesviridae methods of natural killer cell evasion. Adv Virol (2012) 0.80
Cellular events linked to cardiac remodeling in heart failure: targets for pharmacologic intervention. J Cardiovasc Nurs (2000) 0.77